Neurologic complications of cerebral angiography in childhood moyamoya syndrome

• Published in: Pediatric radiology 1998-11, Vol.28 (11), p.824-829
• Main Authors: ROBERTSON, R. L, CHAVALI, R. V, ROBSON, C. D, BARNES, P. D, ELDREDGE, E. A, BURROWS, P. E, SCOTT, R. M
• Format: Article
• Language: English
• Subjects: Adolescent; Anesthesia, General; Biological and medical sciences; Brain Diseases - epidemiology; Brain Diseases - etiology; Cerebral Angiography - adverse effects; Cerebral Angiography - instrumentation; Cerebral Angiography - methods; Cerebral Angiography - statistics & numerical data; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Investigative techniques, diagnostic techniques (general aspects); Male; Medical sciences; Moyamoya Disease - complications; Moyamoya Disease - diagnostic imaging; Nervous system; Radiodiagnosis. Nmr imagery. Nmr spectrometry; Risk Factors
• ISSN: 0301-0449; 1432-1998
• DOI: 10.1007/s002470050474

Purpose. To determine the incidence of neurologic complications of cerebral angiography in children with moyamoya syndrome (MMS) as compared to children without MMS. Materials and methods. One-hundred-ninety consecutive cerebral angiograms obtained in 152 children were evaluated. Sixty of these angiograms were obtained in 40 children with MMS. Patients underwent neurologic evaluation prior to and after the procedure. For this study, a neurologic complication was defined as any new focal neurologic deficit or alteration in mental status occurring during the procedure or within the ensuing 24 hours. Results. There were 2 neurologic complications within 24 hours of angiography, one in the MMS group and one in the non-MMS group. One patient with MMS became mute following angiography. The symptom resolved within 12 hours. One patient without MMS being examined postoperatively for residual arteriovenous malformation developed intracranial hemorrhage requiring reexploration 12 hours after the angiogram. Using a two-tail Fisher's exact test, there was no significant statistical difference in the ischemic (P = 0.3) or hemorrhagic (P = 1.0) complication rates between the group of patients with MMS and the non-MMS groups. Conclusion. The risk of a neurologic complication from cerebral angiography in children with MMS is low and not statistically different from the risk in children with other cerebrovascular disorders.